Skip to main content
  • 42 Accesses

Trade Names

Precose (US), Glucobay, Gluconase, Glumida, Precose, Prandase.

Class and Category

Alpha glucosidase inhibitor, anti-hyperglycemic agent.

Indications

The primary use of acarbose is the management of hyperglycemia in patients with type II diabetes mellitus. A study of 1429 subjects with impaired glucose tolerance randomized to either acarbose or placebo found that acarbose significantly decreased the risk of progression to diabetes and reversed glucose intolerance more frequently than placebo. Acarbose may have a role in the prevention of diabetes in some at-risk patients.

Dosage

Ranges from 50mg to 100mg taken three times daily, taken with the start of each meal.

Contraindications

Acarbose may cause gastrointestinal distress including flatulence, cramping and diarrhea due to the presence of undigested carbohydrates in the bowel. Therefore, patients with colonic obstruction or inflammatory bowel disease, or patients prone to developing intestinal obstructions, should not take...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • (2002) Acarbose. In: Nissen D (ed) Mosby's Drug Consult 13th ed. Mosby, St. Louis

    Google Scholar 

  • Chiasson JL, Josse RG, Gomis R, et al (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359:2072–7

    PubMed  CAS  Google Scholar 

  • Mertes G (2001) Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study. Diabetes Res Clin Pract 52:193–204

    PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag

About this entry

Cite this entry

(2004). Acarbose. In: Moreland, L.W. (eds) Rheumatology and Immunology Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29662-X_10

Download citation

  • DOI: https://doi.org/10.1007/3-540-29662-X_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-20625-5

  • Online ISBN: 978-3-540-29662-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics